GAGNON SECURITIES LLC

13F Filings History

Latest 13F report
Q3 2024 - Nov 12, 2024
Value $
$504M
Signature - Title
Lisa Ferrante - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by GAGNON SECURITIES LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. GAGNON SECURITIES LLC reported 102 stock holdings with total value $504M as of Q3 2024. Top holdings included CDNA, ENSG, AL, ISRG, and WGS.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2024 102 $504M +$32.4M -$51.4M -$19M CDNA, ENSG, AL, ISRG, WGS 13F-HR 11/12/2024, 06:02 AM
Q2 2024 97 $444M +$37.5M -$19M +$18.4M AL, CDNA, ENSG, ISRG, PCRX 13F-HR 8/14/2024, 12:59 PM
Q1 2024 98 $423M +$27.9M -$30.8M -$2.89M AL, ENSG, CDNA, ISRG, PCRX 13F-HR 5/13/2024, 05:16 PM
Q4 2023 102 $417M +$13.6M -$28.8M -$15.2M AL, ENSG, CDNA, ISRG, PCRX 13F-HR 2/14/2024, 05:15 PM
Q3 2023 97 $399M +$7.86M -$35.1M -$27.3M AL, ENSG, ISRG, NVGS, PCRX 13F-HR 11/14/2023, 04:06 PM
Q2 2023 97 $481M +$10.6M -$22.5M -$11.9M AL, ENSG, ISRG, PCRX, PROF 13F-HR 8/8/2023, 05:23 PM
Q1 2023 112 $476M +$45.8M -$25.8M +$20M AL, ENSG, NVGS, PCRX, CDNA 13F-HR 4/10/2023, 04:08 PM
Q4 2022 106 $435M +$11.5M -$30.1M -$18.6M AL, ENSG, PCRX, NVGS, PROF 13F-HR 2/7/2023, 04:42 PM
Q3 2022 101 $455M +$30.5M -$28.3M +$2.24M PCRX, AL, ENSG, CDNA, NVGS 13F-HR 11/14/2022, 04:40 PM
Q2 2022 101 $477M +$34.9M -$22.8M +$12.1M PCRX, AL, ENSG, NVGS, CDNA 13F-HR 8/1/2022, 04:31 PM
Q1 2022 103 $613M +$60.1M -$45.7M +$14.4M PCRX, AL, CDNA, ENSG, NVGS 13F-HR 5/9/2022, 05:09 PM
Q4 2021 104 $667M +$50M -$34.4M +$15.7M AL, AOSL, CDNA, PCRX, ENSG 13F-HR 2/8/2022, 04:06 PM
Q3 2021 112 $673M +$83M -$56.7M +$26.3M CDNA, AL, PCRX, ENSG, AOSL 13F-HR 11/12/2021, 04:43 PM
Q2 2021 111 $704M +$65.3M -$55.9M +$9.34M CDNA, AL, ENSG, AMRC, PCRX 13F-HR 7/28/2021, 02:05 PM
Q1 2021 108 $657M +$59.6M -$60M -$446K CDNA, AL, ENSG, PCRX, GFN 13F-HR 5/14/2021, 05:22 PM
Q4 2020 99 $628M +$30.2M -$14.3M +$15.9M CDNA, AL, AMRC, ENSG, LLFLQ 13F-HR 2/12/2021, 04:17 PM
Q3 2020 97 $467M +$24.2M -$8.51M +$15.7M CDNA, AL, PCRX, ENSG, AMRC 13F-HR 11/12/2020, 04:10 PM
Q2 2020 90 $413M +$16.2M -$26.1M -$9.82M CDNA, AL, PCRX, AMRC, ENSG 13F-HR 8/13/2020, 04:51 PM
Q1 2020 96 $294M +$27M -$70.5M -$43.5M CDNA, AL, ENSG, AMRC, PCRX 13F-HR 5/11/2020, 04:05 PM
Q4 2019 93 $457M +$30.2M -$35.5M -$5.25M AL, GFN, CDNA, EVBG, FIVN 13F-HR 2/14/2020, 04:08 PM
Q3 2019 95 $423M +$12.5M -$17.5M -$5.03M AL, CDNA, GFN, ENSG, FIVN 13F-HR 11/8/2019, 04:10 PM
Q2 2019 97 $464M +$37.9M -$35M +$2.91M CDNA, AL, ENSG, EVBG, GFN 13F-HR 8/12/2019, 04:05 PM
Q1 2019 97 $459M +$54.1M -$35.1M +$19M CDNA, AL, ENSG, EVBG, GFN 13F-HR 5/13/2019, 04:10 PM
Q4 2018 93 $376M +$42.1M -$25.4M +$16.7M CDNA, AL, GFN, ENSG, EVBG 13F-HR 1/18/2019, 04:12 PM
Q3 2018 101 $435M +$83.6M -$20.7M +$62.9M CDNA, GFN, AL, ENSG, EVBG 13F-HR 11/13/2018, 05:21 PM
Q2 2018 97 $337M +$46.3M -$33.7M +$12.7M GFN, CDNA, AL, LLFLQ, RHT 13F-HR 8/9/2018, 04:31 PM
Q1 2018 95 $281M +$9.68M -$29.9M -$20.2M AL, RHT, GFN, CDNA, AMRC 13F-HR 5/9/2018, 05:12 PM
Q4 2017 91 $282M +$18.5M -$17.1M +$1.44M AL, GFN, CDNA, RHT, FIVN 13F-HR 2/13/2018, 02:51 PM
Q3 2017 95 $269M +$28.8M -$25M +$3.8M AL, RHT, LLFLQ, FIVN, SU Restatement 11/14/2017, 05:25 PM
Q2 2017 89 $221M +$38.6M -$47.4M -$8.83M AL, LLFLQ, FIVN, AMBR, GFN 13F-HR 7/20/2017, 02:55 PM
Q1 2017 95 $230M +$4.03M -$12.5M -$8.47M AL, LLFLQ, RHT, ATHN, GFNSL 13F-HR 5/11/2017, 04:36 PM
Q4 2016 95 $232M +$17M -$18.7M -$1.77M AL, RTEC, GFNSL, ATHN, AMBR 13F-HR 2/14/2017, 04:26 PM
Q3 2016 96 $235M +$57.8M -$45.6M +$12.3M AL, ATHN, AMBR, RTEC, LLFLQ 13F-HR 11/14/2016, 04:31 PM
Q2 2016 91 $212M +$35.6M -$27.3M +$8.31M ATHN, EQIX, AL, AMBR, RTEC Restatement 8/24/2016, 10:26 AM
Q1 2016 87 $209M +$21.8M -$20.7M +$1.11M AL, ATHN, EQIX, RHT, RTEC 13F-HR 5/3/2016, 03:44 PM
Q4 2015 84 $218M +$4.92M -$14.5M -$9.53M ATHN, RHT, AL, EQIX, RTEC 13F-HR 2/16/2016, 11:51 AM
Q3 2015 86 $204M +$12.9M -$47.7M -$34.7M RHT, EQIX, AL, ATHN, RTEC 13F-HR 10/16/2015, 11:19 AM
Q2 2015 87 $252M +$9.27M -$37.7M -$28.4M AL, RHT, EQIX, PSIX, ATHN 13F-HR 7/24/2015, 10:49 AM
Q1 2015 92 $301M +$22.8M -$29.1M -$6.27M AL, GFN, RHT, PSIX, EQIX 13F-HR 5/12/2015, 05:26 PM
Q4 2014 93 $311M +$38.9M -$42.5M -$3.6M GFN, EQIX, RHT, CTCT, AL 13F-HR 2/13/2015, 02:07 PM
Q3 2014 97 $299M +$33.8M -$23M +$10.8M GFN, EQIX, AL, ATHN, RHT 13F-HR 10/15/2014, 04:26 PM
Q2 2014 102 $306M +$22.8M -$44.2M -$21.4M GFN, AL, EQIX, CTCT, ATHN 13F-HR 7/31/2014, 01:25 PM
Q1 2014 103 $337M +$46.6M -$58.6M -$12M GFN, AL, ATHN, NVDQ, EQIX 13F-HR 5/6/2014, 04:26 PM
Q4 2013 97 $332M $0 $0 NVDQ, GFN, ATHN, AL, CTCT Restatement 2/6/2014, 01:38 PM